No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment.
CLINICAL TRIAL EVIDENCE FOR GLP-1 RAs IN MASH Table 2 provides a summary of phase 2 and phase 3 studies examining GLP-1 RAs and dual or triple agonists (aiming glucagon, GIP, and GLP-1 receptors) in individuals with MASLD/MASH, where hepatic biopsies were used to evaluate liver outcomes [3,5,10,11,15,22-25,44-52]
Theyve hit their goal: After reaching their target weight, some folks arent ready to quit entirely
Your clinician or lab can advise whether anything should be paused before blood work
Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, et al
Here are some key factors to consider when selecting the best ALCAR product for your needs